{"url_path":"/sec/sonm/8-k/2026-07-02/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 ****Financial","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/1178697/0001493152-26-031675-index.html","accession_number":"0001493152-26-031675","cik":"0001178697","ticker":"SONM","issuer_name":"DNA X, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1178697/0001493152-26-031675-index.html","primary_entity_key":"0001178697","primary_entity_name":"DNA X, Inc."},"word_count":167,"has_tables":true,"body_markdown":"**Item\n9.01****Financial\nStatements and Exhibits.**\n\n \n\n**Exhibit**\n\n**Number**\n\n \n**Description**\n\n3.1\n \n[Form of Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock](ex3-1.htm)\n\n10.1#\n \n[Securities Purchase Agreement, dated June 29, 2026, by and between DNA X, Inc. and DNA Holdings Venture, Inc.](ex10-1.htm)\n\n10.2#\n \n[Form of Registration Rights Agreement by and between DNA X, Inc. and DNA Holdings Venture, Inc.](ex10-2.htm)\n\n104\n \nCover\nPage Interactive Data File-the cover page XBRL tags are embedded within the Inline XBRL document.\n\n \n\n#\nCertain exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2).\n\n \n\nThe\nCompany agrees to furnish supplementally a copy of all omitted exhibits and schedules to the Securities and Exchange Commission upon\nits request.\n\n \n\n \n\n \n\n** **\n\n**SIGNATURES**\n\n** **\n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\n \n \n**DNA X, INC.**\n\n \n \n \n \n\nDate:\nJuly\n2, 2026\nBy:\n*/s/\nClayton Crolius*\n\n \n \nName:\n\nClayton Crolius\n\n \n \nTitle:\nChief Financial Officer"}